Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Anjumn Shabir-Ahmed"'
Autor:
Richard G. Pearson, Tahir Masud, Elaine Blackshaw, Andrew Naylor, Michael Hinchcliffe, Kirk Jeffery, Faron Jordan, Anjumn Shabir-Ahmed, Gareth King, Andrew L. Lewis, Lisbeth Illum, Alan C. Perkins
Publikováno v:
Pharmaceutics, Vol 11, Iss 6, p 265 (2019)
Nasal delivery of large peptides such as parathyroid 1-34 (PTH 1-34) can benefit from a permeation enhancer to promote absorption across the nasal mucosa into the bloodstream. Previously, we have published an encouraging bioavailability (78%), relati
Externí odkaz:
https://doaj.org/article/835f2d5b3a3e42739c1270f537c2dac0
Autor:
Felicity Y. Han, Andrew K. Whittaker, Steven M. Howdle, Andrew Naylor, Anjumn Shabir-Ahmed, Cheng Zhang, Maree T. Smith
Publikováno v:
Pharmaceutics, Vol 10, Iss 4, p 264 (2018)
Pain is inadequately relieved by escalating doses of a strong opioid analgesic such as morphine in up to 25% of patients with cancer-related severe pain complicated by a neuropathic (nerve damage) component. Hence, there is an unmet medical need for
Externí odkaz:
https://doaj.org/article/642895c52bf94bb4b194afe7b11d3364
Sustained-Release Hydromorphone Microparticles Produced by Supercritical Fluid Polymer Encapsulation
Autor:
Anjumn Shabir-Ahmed, Andrew K. Whittaker, Felicity Y. Han, Andrew Naylor, Maree T. Smith, Steven M. Howdle
Publikováno v:
Journal of Pharmaceutical Sciences. 108:811-814
Chronic cancer pain remains prevalent and severe for many patients, particularly in those with advanced disease. The effectiveness of analgesic/adjuvant drug treatments in routine practice has changed little in the last 30 years. To address these iss
Autor:
Andrew Naylor, Tahir Masud, R.G. Pearson, Elaine Blackshaw, Andrew L. Lewis, Anjumn Shabir-Ahmed, Gareth King, Lisbeth Illum, Michael Hinchcliffe, Faron Jordan, Kirk Jeffery, Alan C. Perkins
Publikováno v:
Pharmaceutics, Vol 11, Iss 6, p 265 (2019)
Pharmaceutics
Volume 11
Issue 6
Pharmaceutics
Volume 11
Issue 6
Nasal delivery of large peptides such as parathyroid 1-34 (PTH 1-34) can benefit from a permeation enhancer to promote absorption across the nasal mucosa into the bloodstream. Previously, we have published an encouraging bioavailability (78%), relati